Abstract
Intravitreal clindamycin is one the modalities in managing ocular toxoplasmosis. Here we report clindamycin-induced macular infarct followed by full thickness macular hole with epiretinal membrane and macular atrophy. A 54-year-old male diagnosed with ocular toxoplasmosis in the right eye was treated with intravitreal injection of clindamycin and dexamethasone. Patient developed macular infarction with epiretinal membrane (ERM) and full thickness hole, with corresponding decrease in visual acuity and was managed with vitrectomy. Clindamycin injection has potential to cause retinal complications, and hence, one needs to be extremely cautious while preparing the proper concentration of clindamycin as it requires appropriate dilution.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
